Publications
16
Citations
333
Est. group size
—
Recurring co-author estimate
Active years
8
Publishing since 2019
This researcher works in medicinal chemistry, focusing on designing and synthesizing new small-molecule drug candidates, especially for cancer, tuberculosis, and infectious diseases like leishmaniasis and SARS-CoV-2. Much of the work targets specific cellular proteins involved in cell division (such as tubulin and topoisomerase) or disease-related enzymes, aiming to develop compounds that could become future therapeutic drugs. The work spans both organic synthesis methods and evaluating the biological activity of the resulting compounds.
Publication output was minimal in the mid-2010s, then increased noticeably from 2022 onward, with a peak of five papers per year in 2023 and 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The design and discovery of topoisomerase-II inhibitors as new cancer drugs: current strategies and future perspectives
Expert Opinion on Drug Discovery · 2026
- Recent developments in the discovery of indole-based scaffolds as promising targeted cancer therapeutics
RSC Medicinal Chemistry · 2025
- Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents
ACS Infectious Diseases · 2024
- An update on the development on tubulin inhibitors for the treatment of solid tumors
Expert Opinion on Therapeutic Targets · 2024
- Dual-targeting inhibitors involving tubulin for the treatment of cancer
Bioorganic Chemistry · 2024
- Oxindoline Containing Thiazolidine‐4‐one Tethered Triazoles Act as Antimitotic Agents by Targeting Microtubule Dynamics
ChemistrySelect · 2024
- PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer
Expert Opinion on Therapeutic Targets · 2024
- Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
Pharmaceuticals · 2023
- Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer
ACS Medicinal Chemistry Letters · 2023
- Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1,3,4 Oxadiazoles via Smiles Rearrangement
The Journal of Organic Chemistry · 2023
- 5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against <i>Leishmania Donovani</i>
ChemistrySelect · 2023
- Design and Synthesis of Michael Acceptor‐Based Peptidyl β‐Nitrostyrenes as 3CLpro Inhibitors of SARS‐CoV‐2
ChemistrySelect · 2023
- Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked Bis-Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K
Molecules · 2022
- Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design
Expert Opinion on Drug Discovery · 2022
- Regioselective C–H alkylation and alkenylation at the C5 position of 2-amino-1,4-naphthoquinones with maleimides under Rh( <scp>iii</scp> ) catalysis
Organic Chemistry Frontiers · 2019
- ChemistrySelect×3
- Expert Opinion on Therapeutic Targets×2
- Expert Opinion on Drug Discovery×2
- Pharmaceuticals×1
- ACS Infectious Diseases×1
- Kumar Nikhil
Chemistry · Purdue University West Lafayette
- Kavita Shah
Chemistry · Purdue University West Lafayette
- Eman Ahmed
Chemistry · The Ohio State University
- Chelsea A. Mann
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Asif Raza
Chemistry · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile